parinaric acid has been researched along with Alloxan Diabetes in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Heyliger, CE; Powell, DM; Skau, KA | 1 |
Bernlohr, DA; Coles, SM; Fraser, H; Frolov, AA; Grund, V; Murphy, EJ; Schroeder, F; Woodford, JK | 1 |
Eymer, VP; Heyliger, CE; Powell, DM; Scarim, AL; Skau, KA | 1 |
3 other study(ies) available for parinaric acid and Alloxan Diabetes
Article | Year |
---|---|
Effect of hydralazine on myocardial plasma membrane fatty acid binding protein (PM-FABP) during diabetes mellitus.
Topics: Animals; Antihypertensive Agents; Carrier Proteins; Diabetes Mellitus, Experimental; Fatty Acid-Binding Protein 7; Fatty Acid-Binding Proteins; Fatty Acids, Unsaturated; Hydralazine; Hyperlipidemias; Hypolipidemic Agents; Lipids; Male; Myelin P2 Protein; Myocardium; Neoplasm Proteins; Nerve Tissue Proteins; Rats; Rats, Wistar; Streptozocin | 1995 |
Fatty acid uptake in diabetic rat adipocytes.
Topics: Adipocytes; Animals; Biological Transport; Carrier Proteins; Cell Membrane; Cytosol; Diabetes Mellitus, Experimental; Fatty Acid-Binding Protein 7; Fatty Acid-Binding Proteins; Fatty Acids; Fatty Acids, Unsaturated; Insulin; Male; Myelin P2 Protein; Neoplasm Proteins; Nerve Tissue Proteins; Rats; Rats, Wistar | 1997 |
Characteristics of the myocardial PM-FABP: effect of diabetes mellitus.
Topics: Animals; Cardiomyopathies; Carrier Proteins; Diabetes Mellitus, Experimental; Fatty Acid-Binding Protein 7; Fatty Acid-Binding Proteins; Fatty Acids, Nonesterified; Fatty Acids, Unsaturated; Fluorescent Dyes; Heart; Male; Myelin P2 Protein; Myocardium; Neoplasm Proteins; Nerve Tissue Proteins; Rats; Rats, Wistar; Streptozocin; Triglycerides; Trypsin | 1997 |